Please login to the form below

Not currently logged in
Email:
Password:

AZD0914

This page shows the latest AZD0914 news and features for those working in and with pharma, biotech and healthcare.

Cubist antibiotic to get priority review in US

Cubist antibiotic to get priority review in US

It is the second boost for new antibiotics in the US this month after the FDA's decision to grant fast track status to AstraZeneca's AZD0914 for the sexually transmitted

Latest news

  • FDA fast-tracks new AstraZeneca antibiotic FDA fast-tracks new AstraZeneca antibiotic

    FDA. AZD0914 has shown promise as a treatment for the sexually transmitted infection (STI) uncomplicated gonorrhoea, which, like other infectious diseases, is growing increasingly resistant to existing antibiotics. ... AZD0914 is also classed as a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics